“What else can we do?”—Provider perspectives on treatment‐resistant depression in late life-Reference-Cited by-同舟云学术

“What else can we do?”—Provider perspectives on treatment‐resistant depression in late life

Published:2021-12-03 Issue: Volume: Page:
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J American Geriatrics Society

Author:

Hamm Megan E.¹,Karp Jordan F.²,Lenard Emily³,Dawdani Alicia¹,Lavretsky Helen⁴,Lenze Eric J.³,Mulsant Benoit H.⁵,Reynolds Charles F.⁶,Roose Steven P.⁷,Brown Patrick J.⁷

Affiliation:

1. Department of General Internal Medicine University of Pittsburgh Pittsburgh Pennsylvania USA

2. Department of Psychiatry, College of Medicine University of Arizona Tucson Arizona USA

3. Department of Psychiatry Washington University School of Medicine in St. Louis St. Louis Missouri USA

4. Department of Psychiatry and Biobehavioral Sciences University of California Los Angeles California USA

5. Centre for Addiction and Mental Health, Department of Psychiatry, Temerty Faculty of Medicine University of Toronto Toronto Canada

6. School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA

7. Department of Psychiatry Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute New York New York USA

Funder

Patient-Centered Outcomes Research Institute

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.17592

Reference42 articles.

1. Predicting Remission in Late-Life Major Depression

2. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial

3. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment‐resistant late‐life depression

4. Systematic Review of Cognitive Effects of Electroconvulsive Therapy in Late-Life Depression

5. Clinical diagnosis of depression in primary care: a meta-analysis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment resistant late-life depression: A narrative review of psychosocial risk factors, non-pharmacological interventions, and the role of clinical phenotyping;Journal of Affective Disorders;2024-07

2. The clinical perspective on late-onset depression in European real-world treatment settings;European Neuropsychopharmacology;2024-07

3. Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials;PLOS ONE;2024-04-26

4. Low Functional network integrity in cognitively unimpaired and MCI subjects with depressive symptoms: results from a multi-center fMRI study;Translational Psychiatry;2024-04-05

5. Patient and provider perspectives on the phenomenon and effective treatment of treatment-resistant depression: A grounded theory;Journal of Affective Disorders Reports;2024-04